✦ LIBER ✦

Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563

✍ Scribed by J.M Langrehr; R Lohmann; R Raakow; S Jonas; J Klupp; W.O Bechstein; R Neuhaus; P Neuhaus

Book ID: 117230948
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 65 KB
Volume: 33
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(01)01993-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IL-2 receptor antibody induction increas

IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation

✍ J.M Langrehr; R Lohmann; O Guckelberger; A.R Müller; R Raakow; N.C Nüssler; J Kl 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Pharmacodynamics of prophylactic antirej

Pharmacodynamics of prophylactic antirej ection therapy with an anti interleukin-2 receptor monoclonal antibody (BT563) after heart and kidney transplantation

✍ Cees J. Hesse; Teun van Gelder; Lennard M.B. Vaessen; Christiaan J. Knoop; Aggie 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 746 KB

Induction therapy with interleukin-2 rec

Induction therapy with interleukin-2 receptor antagonist after intestinal transplantation is associated with reduced acute cellular rejection and improved renal function

✍ D.G Farmer; S.V McDiarmid; S Edelstein; J.F Renz; G Hisatake; G Cortina; C Fonde 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Interleukin-2 receptor antibody (basilix

Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: A protocol with early elimination of steroids and reduction of tacrolimus dosage

✍ Chi Leung Liu; Sheung Tat Fan; Chung Mau Lo; See Ching Chan; Irene O. Ng; Ching 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

A prospective evaluation was performed to study the potential benefits of the use of interleukin-2 receptor antibody (IL-2Rab) in the induction therapy with early elimination of steroid and reduction of tacrolimus dosage in liver transplant recipients among whom 94% had chronic hepatitis B infection